Australia's star vaccine maker not immune to virus anxiety

Earlier this year, a low-key biomedical firm briefly toppled Australia's biggest bank and miner to become the country's most expensive company and a household brand, thanks to its part in the race to produce a Covid-19 vaccine. But while the coronavirus pandemic has lifted CSL Ltd's CSL.AX investment profile, virus anxieties are also hitting its most lucrative business: taking